Ambulatory Hypertension Subtypes and 24-Hour Systolic and Diastolic Blood Pressure as Distinct Outcome Predictors in 8341 Untreated People Recruited From 12 Populations

Yan Li(Shanghai Institute of Hypertension), Fang‐Fei Wei(Shanghai Institute of Hypertension), Lutgarde Thijs(Shanghai Institute of Hypertension), José Boggia(Universidad de la República de Uruguay), Kei Asayama(Shanghai Institute of Hypertension), Tine W. Hansen(Shanghai Institute of Hypertension), Masahiro Kikuya(Shanghai Institute of Hypertension), Kristina Björklund‐Bodegârd(Shanghai Institute of Hypertension), Takayoshi Ohkubo(Shanghai Institute of Hypertension), Jørgen Jeppesen(Shanghai Institute of Hypertension), Yu-Mei Gu(Shanghai Institute of Hypertension), Christian Torp‐Pedersen(Shanghai Institute of Hypertension), Eamon Dolan(Shanghai Institute of Hypertension), Yan-Ping Liu(Shanghai Institute of Hypertension), Tatiana Kuznetsova(Shanghai Institute of Hypertension), Katarzyna Stolarz‐Skrzypek(Shanghai Institute of Hypertension), Valérie Tikhonoff(University of Padua), Sofia Malyutina(Shanghai Institute of Hypertension), Edoardo Casiglia(University of Padua), Yuri Nikitin(Shanghai Institute of Hypertension), Lars Lind(Shanghai Institute of Hypertension), Edgardo Sandoya(Shanghai Institute of Hypertension), Kalina Kawecka−Jaszcz(University of Padua), Luis J. Mena(Universidad del Zulia), Gladys E. Maestre(Universidad del Zulia), Jan Filipovský(Shanghai Institute of Hypertension), Yutaka Imai(Shanghai Institute of Hypertension), Eoin O’Brien(University College Dublin), Ji-Guang Wang(Shanghai Institute of Hypertension), Jan A. Staessen(Shanghai Institute of Hypertension)
Circulation
June 7, 2014
Cited by 112Open Access
Full Text

Abstract

BACKGROUND: Data on risk associated with 24-hour ambulatory diastolic (DBP24) versus systolic (SBP24) blood pressure are scarce. METHODS AND RESULTS: We recorded 24-hour blood pressure and health outcomes in 8341 untreated people (mean age, 50.8 years; 46.6% women) randomly recruited from 12 populations. We computed hazard ratios (HRs) using multivariable-adjusted Cox regression. Over 11.2 years (median), 927 (11.1%) participants died, 356 (4.3%) from cardiovascular causes, and 744 (8.9%) experienced a fatal or nonfatal cardiovascular event. Isolated diastolic hypertension (DBP24≥80 mm Hg) did not increase the risk of total mortality, cardiovascular mortality, or stroke (HRs≤1.54; P≥0.18), but was associated with a higher risk of fatal combined with nonfatal cardiovascular, cardiac, or coronary events (HRs≥1.75; P≤0.0054). Isolated systolic hypertension (SBP24≥130 mm Hg) and mixed diastolic plus systolic hypertension were associated with increased risks of all aforementioned end points (P≤0.0012). Below age 50, DBP24 was the main driver of risk, reaching significance for total (HR for 1-SD increase, 2.05; P=0.0039) and cardiovascular mortality (HR, 4.07; P=0.0032) and for all cardiovascular end points combined (HR, 1.74; P=0.039) with a nonsignificant contribution of SBP24 (HR≤0.92; P≥0.068); above age 50, SBP24 predicted all end points (HR≥1.19; P≤0.0002) with a nonsignificant contribution of DBP24 (0.96≤HR≤1.14; P≥0.10). The interactions of age with SBP24 and DBP24 were significant for all cardiovascular and coronary events (P≤0.043). CONCLUSIONS: The risks conferred by DBP24 and SBP24 are age dependent. DBP24 and isolated diastolic hypertension drive coronary complications below age 50, whereas above age 50 SBP24 and isolated systolic and mixed hypertension are the predominant risk factors.


Related Papers

No related papers found

Powered by citation graph analysis